Mass Spectrometry Identification of Immunoglobulin Free Light Chains
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting immunoglobulin free light chains in clinical medicine are not specific for individual kappa and lambda chains, relying on kappa/lambda ratios that can be affected by polyclonal backgrounds and autoimmune conditions, making it difficult to accurately diagnose monoclonal gammopathies.
Innovation Solution
A method using mass spectrometry techniques, such as LC-MS/MS, to directly quantify and identify kappa and lambda immunoglobulin free light chains in samples, including glycosylated and cysteinylated forms, without the need for specific antibodies, allowing for precise detection in the presence of polyclonal backgrounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current methods using kappa/lambda ratios are used for detecting immunoglobulin free light chains, then the detection process is simple, but the measurement precision is poor due to interference from polyclonal backgrounds and autoimmune conditions
Solution Approach 1:
The patent replaces traditional immunoassay methods with mass spectrometry technology. The mass spectrometer detects and quantifies free light chains based on their unique mass-to-charge ratios, eliminating the need for antibody-based detection systems. This substitution provides superior measurement precision by directly measuring the mass of individual light chain molecules, thereby resolving the technical contradiction between simple detection and accurate measurement.
2Measurement precision
If mass spectrometry techniques are used to identify immunoglobulin free light chains, then the measurement precision is improved, but the device complexity increases
Solution Approach 1:
The mass spectrometry system performs self-identification of free light chains through their intrinsic mass characteristics. The system automatically detects, identifies, and quantifies kappa and lambda light chains based on their unique mass spectra without requiring external calibration standards or complex sample preparation protocols. This self-service capability manages the device complexity by making the system autonomous in its analytical process.
Solution Approach 2:
The patent utilizes the fundamental parameter of mass-to-charge ratio to differentiate and quantify free light chains. By measuring the precise mass of individual light chain molecules and their glycosylated forms, the system achieves high measurement precision. This parameter-based approach transforms the complex problem of distinguishing similar proteins into a straightforward mass measurement task, effectively managing system complexity while improving accuracy.
3Reliability
If traditional immunoassay methods are used, then the ease of operation is maintained, but the reliability is reduced due to inability to distinguish monoclonal gammopathies from autoimmune responses
Solution Approach 1:
The mass spectrometry system segments the detection process into distinct analytical steps: ionization of sample molecules, separation based on mass-to-charge ratio, detection of individual ion signals, and computational analysis of mass spectra. This segmentation allows the system to resolve and quantify specific free light chain types (kappa and lambda) and their glycosylated forms independently, providing reliable diagnostic information that distinguishes monoclonal gammopathies from autoimmune responses while maintaining operational simplicity through automated analysis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables accurate quantitation and identification of immunoglobulin free light chains, distinguishing monoclonal gammopathies from autoimmune responses and polyclonal backgrounds, providing a more reliable diagnostic tool for plasma cell dyscrasias and related disorders.
Implementation Method 1
subjecting the sample to a mass spectrometry technique to obtain a mass spectrum of the sample
Data Source
AI summary
This document relates to methods for identifying one or more immunoglobulin free light chains in a sample using mass spectrometry. For example, this document relates to a method for identifying one or more immunoglobulin free light chains in a sample that includes (a) providing a sample; (b) subjecting the sample to a mass spectrometry technique to obtain a mass spectrum of the sample; and (c) identifying the presence of the one or more immunoglobulin free light chains.